New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial
Authors
Keywords
-
Journal
LANCET INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-04-07
DOI
10.1016/s1473-3099(20)30844-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers
- (2021) Isabela Ribeiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New scheme of intermittent benznidazole administration in patients chronically infected with Trypanosoma cruzi: Clinical, parasitological and serological assessment after three years of follow-up.
- (2020) María Gabriela Álvarez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Longitudinal follow up of serological response in children treated for Chagas disease
- (2019) Guillermo Moscatelli et al. PLoS Neglected Tropical Diseases
- Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease
- (2019) Yves Jackson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice
- (2018) Lívia de Figueiredo Diniz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection: A systematic review and meta-analysis of individual participant data
- (2018) Yanina Sguassero et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
- (2018) Faustino Torrico et al. LANCET INFECTIOUS DISEASES
- Clinical and pharmacological profile of benznidazole for treatment of Chagas disease
- (2018) Jadel Müller Kratz et al. Expert Review of Clinical Pharmacology
- Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers
- (2017) Carlos A. Morillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Estimating the Burden of Chagas Disease in the United States
- (2016) Jennifer Manne-Goehler et al. PLoS Neglected Tropical Diseases
- Population Pharmacokinetics of Benznidazole in Adult Patients with Chagas Disease
- (2015) D. Soy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients
- (2015) Juan Carlos Ramírez et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives
- (2015) Maria-Jesus Pinazo et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
- (2014) Israel Molina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults
- (2014) Jaime Altcheh et al. PLoS Neglected Tropical Diseases
- New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice
- (2013) J. M. Bustamante et al. JOURNAL OF INFECTIOUS DISEASES
- Improved Completion Rates and Characterization of Drug Reactions with an Intensive Chagas Disease Treatment Program in Rural Bolivia
- (2013) Jeffrey A. Tornheim et al. PLoS Neglected Tropical Diseases
- Posttherapeutic Cure Criteria in Chagas' Disease: Conventional Serology followed by Supplementary Serological, Parasitological, and Molecular Tests
- (2012) G. F. Machado-de-Assis et al. Clinical and Vaccine Immunology
- Safety of benznidazole use in the treatment of chronic Chagas' disease
- (2012) A. M. Hasslocher-Moreno et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease
- (2012) M.G. Álvarez et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Tolerance of Benznidazole in Treatment of Chagas' Disease in Adults
- (2010) M.-J. Pinazo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adverse Events After the Use of Benznidazole in Infants and Children With Chagas Disease
- (2010) J. Altcheh et al. PEDIATRICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now